Literature DB >> 28847731

KSRP suppresses cell invasion and metastasis through miR-23a-mediated EGR3 mRNA degradation in non-small cell lung cancer.

Ming-Hsien Chien1, Wei-Jiunn Lee2, Yi-Chieh Yang3, Yin-Lin Li4, Bo-Rong Chen5, Tsu-Yao Cheng6, Pei-Wen Yang5, Ming-Yang Wang5, Yi-Hua Jan7, Yen-Kuang Lin8, Jang-Ming Lee5, Michael Hsiao7, Jin-Shing Chen9, Kuo-Tai Hua10.   

Abstract

KH-type splicing regulatory protein (KSRP) is a single-strand RNA binding protein which regulates mRNA stability either by binding to AU-rich elements (AREs) of mRNA 3'UTR or by facilitating miRNA biogenesis to target mRNA. Unlike its well-characterized function at the molecular level in maintaining RNA homeostasis, the role of KSRP in cancer progression remains largely unknown. Here we investigate the role of KSRP in non-small cell lung cancer (NSCLC). We first examined KSRP expression by immunohistochemistry in a cohort containing 196 NSCLC patients and observed a strong positive correlation between KSRP expression and survival of NSCLC patients. Multivariate analysis further identified KSRP as an independent prognostic factor. Manipulating KSRP expression significantly affected in vitro cell mobility and in vivo metastatic ability of NSCLC cells. Microarray analysis identified an ARE-containing gene, EGR3, as a downstream effector of KSRP in NSCLC. Interestingly, we found that KSRP decreased EGR3 mRNA stability in an ARE-independent manner. By screening KSRP-regulated miRNAs in NSCLC cells, we further found that miR-23a directly binds to EGR3 3'UTR, reducing EGR3 expression and thereby inhibiting NSCLC cell mobility. Our findings implicate a targetable KSRP/miR-23a/EGR3 signaling axis in advanced tumor phenotypes.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell invasion; KSRP; Metastasis; mRNA decay; miRNA processing

Mesh:

Substances:

Year:  2017        PMID: 28847731     DOI: 10.1016/j.bbagrm.2017.08.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  12 in total

1.  KSRP modulates melanoma growth and efficacy of vemurafenib.

Authors:  Wenwen Liu; Chu-Fang Chou; Shanrun Liu; David Crossman; Nabiha Yusuf; Yunkun Wu; Ching-Yi Chen
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2019-06-30       Impact factor: 4.490

2.  LncRNA MALAT1 Promotes the Proliferation, Migration, and Invasion of Melanoma Cells by Downregulating miR-23a.

Authors:  Pan Wang; Liu Hu; Guili Fu; Jingjing Lu; Yuanquan Zheng; Ying Li; Lin Jia
Journal:  Cancer Manag Res       Date:  2020-07-29       Impact factor: 3.989

Review 3.  The Role of KH-Type Splicing Regulatory Protein (KSRP) for Immune Functions and Tumorigenesis.

Authors:  Kim-Alicia Palzer; Vanessa Bolduan; Rudolf Käfer; Hartmut Kleinert; Matthias Bros; Andrea Pautz
Journal:  Cells       Date:  2022-04-28       Impact factor: 7.666

4.  miR-454-3p promotes of human glioma cell growth by targeting EGR3.

Authors:  Guoliang Shen; Jian Wu; Zhaohui Mou; Danlong Chen; Li Liu; Xing Li
Journal:  Exp Ther Med       Date:  2019-09-25       Impact factor: 2.447

5.  RNA-binding protein MSI2 isoforms expression and regulation in progression of triple-negative breast cancer.

Authors:  Ming Li; An-Qi Li; Shu-Ling Zhou; Hong Lv; Ping Wei; Wen-Tao Yang
Journal:  J Exp Clin Cancer Res       Date:  2020-05-24

6.  RNA-binding protein KHSRP promotes tumor growth and metastasis in non-small cell lung cancer.

Authors:  Mingxia Yan; Lei Sun; Jing Li; Huajian Yu; Hechun Lin; Tao Yu; Fangyu Zhao; Miaoxin Zhu; Lei Liu; Qin Geng; Hanwei Kong; Hongyu Pan; Ming Yao
Journal:  J Exp Clin Cancer Res       Date:  2019-11-27

Review 7.  Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.

Authors:  Ahmad Najem; Laura Soumoy; Malak Sabbah; Mohammad Krayem; Ahmad Awada; Fabrice Journe; Ghanem E Ghanem
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

8.  XIST promotes apoptosis and the inflammatory response in CSE-stimulated cells via the miR-200c-3p/EGR3 axis.

Authors:  Panfeng Chen; Ping Jiang; Jianing Chen; Yang Yang; Xiumei Guo
Journal:  BMC Pulm Med       Date:  2021-07-09       Impact factor: 3.317

9.  Expression and prognostic value of the transcription factors EGR1 and EGR3 in gliomas.

Authors:  Arnon Møldrup Knudsen; Ida Eilertsen; Susanne Kielland; Mikkel Warming Pedersen; Mia Dahl Sørensen; Rikke Hedegaard Dahlrot; Henning Bünsow Boldt; Sune Munthe; Frantz Rom Poulsen; Bjarne Winther Kristensen
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

10.  Therapeutic targeting with DABIL-4 depletes myeloid suppressor cells in 4T1 triple-negative breast cancer model.

Authors:  Sadiya Parveen; Sumit Siddharth; Laurene S Cheung; Alok Kumar; Jessica Shen; John R Murphy; Dipali Sharma; William R Bishai
Journal:  Mol Oncol       Date:  2021-03-24       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.